TEL AVIV: Plantish has developed a 100 percent plant-based salmon fillet that replicates every aspect of conventional fish.
The successful development is a result of proprietary patent-pending manufacturing technology.
Products will eventually be available for manufacturing on a large scale but at low cost to the consumer.
The product itself has the same nutritional value as regular salmon, including protein, omega fats, and B vitamins. It negates bones, but has a tangible structure and looks like real salmon. It contains none of the toxins that are frequently identified in regular fillets though—mercury, microplastics, hormones, and antibiotics included.
“Our vision is to be the world’s leading seafood brand,” co-founder and CEO Ofek Ron said in a company statement, “all without hurting a single fish.”
“Using the right plant proteins to achieve the fibrous strands meant to replicate the complex texture of animal muscle is the key to succeeding in capturing the experience of eating salmon, and doing so at scale will make it a suitable substitute for foodservice, restaurants, and retail,” the company revealed in a statement.
The salmon prototype can be cooked identically to conventional salmon. Irst consumer interactions are slated for late 2022, at a number of pop-up events. Full commercial launch is currently planned for 2024.